HIV-1 viruses, which are predominant in the family of HIV viruses, have strong pathogenicity and infectivity. They can evolve into many different variants in a very short time. In this study, we propose a new and effective alignment-free method for the phylogenetic analysis of HIV-1 viruses using complete genome sequences. Our method combines the position distribution information and the counts of the k-mers together. We also propose a metric to determine the optimal k value. We name our method the Position-Weighted k-mers (PWkmer) method. Validation and comparison with the Robinson–Foulds distance method and the modified bootstrap method on a benchmark dataset show that our method is reliable for the phylogenetic analysis of HIV-1 viruses. PWkmer can resolve within-group variations for different known subtypes of Group M of HIV-1 viruses. This method is simple and computationally fast for whole genome phylogenetic analysis.
Genome-wide association study (GWAS) has turned out to be an essential technology for exploring the genetic mechanism of complex traits. To reduce the complexity of computation, it is well accepted to remove unrelated single nucleotide polymorphisms (SNPs) before GWAS, e.g., by using iterative sure independence screening expectation-maximization Bayesian Lasso (ISIS EM-BLASSO) method. In this work, a modified version of ISIS EM-BLASSO is proposed, which reduces the number of SNPs by a screening methodology based on Pearson correlation and mutual information, then estimates the effects via EM-Bayesian Lasso (EM-BLASSO), and finally detects the true quantitative trait nucleotides (QTNs) through likelihood ratio test. We call our method a two-stage mutual information based Bayesian Lasso (MBLASSO). Under three simulation scenarios, MBLASSO improves the statistical power and retains the higher effect estimation accuracy when comparing with three other algorithms. Moreover, MBLASSO performs best on model fitting, the accuracy of detected associations is the highest, and 21 genes can only be detected by MBLASSO in Arabidopsis thaliana datasets.
Motivation
Infection with strains of different subtypes and the subsequent crossover reading between the two strands of genomic RNAs by host cells’ reverse transcriptase are the main causes of the vast HIV-1 sequence diversity. Such inter-subtype genomic recombinants can become circulating recombinant forms (CRFs) after widespread transmissions in a population. Complete prediction of all the subtype sources of a CRF strain is a complicated machine learning problem. It is also difficult to understand whether a strain is an emerging new subtype and if so, how to accurately identify the new components of the genetic source.
Results
We introduce a multi-label learning algorithm for the complete prediction of multiple sources of a CRF sequence as well as the prediction of its chronological number. The prediction is strengthened by a voting of various multi-label learning methods to avoid biased decisions. In our steps, frequency and position features of the sequences are both extracted to capture signature patterns of pure subtypes and CRFs. The method was applied to 7185 HIV-1 sequences, comprising 5530 pure subtype sequences and 1655 CRF sequences. Results have demonstrated that the method can achieve very high accuracy (reaching 99%) in the prediction of the complete set of labels of HIV-1 recombinant forms. A few wrong predictions are actually incomplete predictions, very close to the complete set of genuine labels.
Availability
https://github.com/Runbin-tang/The-source-of-HIV-CRFs-prediction
Contact
yuzuguo@aliyun.com;jinyan.li@uts.edu.au
Supplementary information
Supplementary data are available at Bioinformatics online.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.